Compositions for management of acute nephrotoxicity

A composition enriched with bisdemethoxycurcumin standardized to contain 20-80% w/w bisdemethoxycurcumin, 10-35% w/w demethoxycurcumin and 10-50% w/w curcumin. More specifically the invention discloses the potential of a composition comprising 20-80% w/w bisdemethoxycurcumin, 10-35% w/w demethoxycur...

Full description

Saved in:
Bibliographic Details
Main Authors Majeed, Muhammed, Ibrahim, A. Muhamad, Nagabhushanam, Kalyanam, Mundkur, Lakshmi
Format Patent
LanguageEnglish
Published 06.08.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A composition enriched with bisdemethoxycurcumin standardized to contain 20-80% w/w bisdemethoxycurcumin, 10-35% w/w demethoxycurcumin and 10-50% w/w curcumin. More specifically the invention discloses the potential of a composition comprising 20-80% w/w bisdemethoxycurcumin, 10-35% w/w demethoxycurcumin and 10-50% w/w curcumin in the management of nephrotoxicity in mammals. The composition further comprises a Nigella sativa extract standardised to contain not less than 2% w/w thymoquinone and about 0.01%-10% w/w thymohydroquinone.
Bibliography:Application Number: US202117644990